Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 599-602

  Sasaki, Hidefumi ^a   Shitara, Masayuki ^a   Yokota, Keisuke ^a   Hikosaka, Yu ^a   Moriyama, Satoru ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

EGFR; Glucose transporter 1; Kras; Lung cancer; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTER 1; K RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING;

EID: 84856264409     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.736     Document Type: Article

References (34)

1. Ginsberg RJ, Kris MK and Armstrong JG: Cancer of the Lung: Principles and Practice of Oncology. 4th edition, Lippincott, Philadelphia, pp673-682, 1993.
2. Ueda Y, Fujii Y and Kuwano H: Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 57: 488-513, 2009.
3. Postus PE, on behalf of the Lung Cancer Cooperative Group of the EORTC: The experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. Chest (Suppl 113): S28-S31, 1997.
4. Isselbacher KJ: Sugar and amino acid transport by cells in culture-differences between normal and malignant cells. N Engl J Med 286: 929-933, 1972.
5. Thorens B and Mueckler M: Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298: E141-E145, 2010.
6. Suganuma N, Segade F, Matsuzu K and Bowden DW: Differential expression of facilitative glucose transporters in normal and tumor kidney tissues. BJU Int 99: 1143-1149, 2007. (Pubitemid 46587915)
7. Yamamoto T, Seino Y, Fukumoto H, et al: Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170: 223-230, 1990. (Pubitemid 20249408)
8. Brown RS and Wahl RL: Overexpression of GLUT-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72: 2979-2985, 1993. (Pubitemid 23335044)
9. Haber RS, Rathan A and Weiser KR: GLUT-1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83: 34-40, 1998. (Pubitemid 28299626)
10. Cantuaria G, Fagotti A and Ferrandina G: GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer 92: 1144-1150, 2001. (Pubitemid 32861663)
11. Ogawa J, Inoue H and Koide S: Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer. Int J Cancer 74: 189-192, 1997. (Pubitemid 27234509)
12. Birnbaum MJ, Haspel HC and Rosen OM: Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci USA 83: 5784-5788, 1986. (Pubitemid 16000596)
13. Fukumoto H, Seino S, Imura H, Seino Y and Bell GI: Characterization and expression of human HepG2/erythrocyte glucose transporter gene. Diabetes 37: 657-661, 1988.
14. Yun J, Rago C, Cheong I, et al: Glucose deprivation contributes to the development of Kras pathway mutations in tumor cells. Science 325: 1555-1559, 2009.
15. Sasaki H, Hikosaka Y, Kawano O, et al: Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer. J Thorac Oncol 6: 15-20, 2011.
16. Sasaki H, Okuda K, Kawano O, et al: Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol Rep 18: 623-628, 2007.
17. Usuda K, Sagawa M, Aikawa H, et al: Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer. Gen Thorac Cardiovasc Surg 58: 405-410, 2010.
18. Sasaki H, Shimizu S, Endo K, et al: EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer 118: 180-184, 2006. (Pubitemid 41681596)
19. Endo K, Konishi A, Sasaki H, et al: Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50: 375-384, 2005.
20. Sasaki H, Endo K, Konishi A, et al: EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 11: 2924-2929, 2005. (Pubitemid 40525194)
21. Endo K, Sasaki H, Yano M, et al: Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy. Oncol Rep 16: 533-541, 2006.
22. Kallinowski F, Schlenger KH, Kunkel S, Kloes M, Stohrer M, Okunieff P and Vaupel P: Blood flow, metabolism, cellular microenvironment and growth rate of human tumor xenography. Cancer Res 49: 3759-3764, 1989. (Pubitemid 19197393)
23. Chiche J, Brahimi-Horn MC and Pouyssegur J: Tumor hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 14: 771-794, 2010.
24. Heber D, Byerley LO and Tchekmedyian NS: Hormonal and metabolic abnormalities in the malnourished cancer patients: effects on host-tumor interaction. JPEN J Parenter Enteral Nutr 16 (Suppl 6): S60-S64, 1992.
25. Macheda ML, Rogers S and Best JD: Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202: 654-662, 2005. (Pubitemid 40175840)
26. Smith TA: Facilitative glucose transporter expression in human cancer tissue. Br J Biomed Sci 56: 285-292, 1999.
27. Airley RE and Mobasheri A: Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53: 233-256, 2007. (Pubitemid 47074647)
28. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004. (Pubitemid 39070849)
29. Kiaris H and Spandidos DA: Mutations of ras genes in human tumors (Review). Int J Oncol 7: 413-421, 1995.
30. Kim JW, Gao P and Dang CV: Effects of hypoxia on tumor metabolism. Cancer Metastasis Rev 26: 291-298, 2007. (Pubitemid 47103157)
31. Gatenby RA and Gillies RJ: Who do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004. (Pubitemid 39472955)
32. Gillies RJ, Robey I and Gatenby RA: Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49 (Suppl 2): S24-S42, 2008.
33. Hsu PP and Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707, 2008.
34. Vander Heiden MG, Cantley LC and Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.